cineolhaltige composition for the treatment of nasal diseases

摘要

composition, in particular pharmaceutical compositionthe use of prophylactic and / or therapeutic treatment of rhinosinusitis with nasal polyps (polyposis nasi et sinuum) (rswnp)in particular, chronic rhinosinusitis with nasal polyps (polyposis nasi et sinuum) (crswnp)with the composition as active ingredient, in particular pharmaceutical active substance, preferably cineol, 1.8 - cineol, contains andwith the rhinosinusitis with nasal polyps (polyposis nasi et sinuum) (rswnp), particularly chronic rhinosinusitis with nasal polyps (polyposis nasi et sinuum) (crswnp)a nitric oxide (no) metabolism, preferably one with the activity and / or regulation of at least one of nitric oxide synthase (nos),in particular, the endothelial nitric oxide synthase (enos), related, and / or with associated disease.